iGMDRD677
Canonical SMILES: CC1(CCC(=C(C1)C2=CC=C(C=C2)Cl)CN3CCN(CC3)C4=CC(=C(C=C4)C(=O)NS(=O)(=O)C5=CC(=C(C=C5)NCC6CCOCC6)[N+](=O)[O-])OC7=CN=C8C(=C7)C=CN8)C
InChI: InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)
InChI Key: LQBVNQSMGBZMKD-UHFFFAOYSA-N
Loading, please wait...
Standard Name | CHEMBL | Pubchem CID | DRUGBANK ID | Drug Status | Drug Type |
---|---|---|---|---|---|
Standard NameABT-199 (GDC-0199) CHEMBLCHEMBL3137309 Pubchem CID49846600 DRUGBANK IDDB11581 Drug StatusAlone Drug TypeSmall Molecule |
Drug Class:
AmidesAntineoplastic AgentsBCL-2 InhibitorBCRP/ABCG2 SubstratesBicyclo CompoundsBridged CompoundsHeterocyclic CompoundsHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Bridged-RingHydrocarbonsHydrocarbons, CyclicP-glycoprotein/ABCB1 SubstratesPolycyclic CompoundsSulfonesSulfur CompoundsDrug Targets:
BCL2 (P10415)Drug-model tissue-cancer distribution: Bubble Plot
Drug-gene pathway enrichments
Drug-gene GO enrichments
Drug-Gene: Aster Plot
Gene in drug-gene network: Network Plot

Models in ABT-199 (GDC-0199)
Loading, please wait...
Model | Level | Reference ID | Tissue | Cancer | Drug | Clinical Response | Source | |
---|---|---|---|---|---|---|---|---|
No matching records found |